Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON).
Clinical trial NCT03164616 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03164616
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-01
- Primary completion
- 2021-03-12
- Enrollment
- 1186
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.